Amazon.com reportedly has talked to makers of generic drugs, including Mylan and Sandoz, about a potential entry into the pharmacy space.

The conversations may be about Amazon taking a role in drug purchasing, competing against distributors like McKesson, AmerisourceBergen, and Cardinal Health, CNBC reported.

But sources agree Amazon's plans remain vague, and some are skeptical that the e-commerce giant will pull the trigger, CNBC reported.

Amazon’s entry into pharmaceuticals has been long rumored in the media.

Last month, Reuters reported that Amazon was said to be in discussions with mid-market pharmacy benefit managers and has been hiring talent to assess the drug retailing market for its entry,

“We are convinced that AMZN will almost certainly enter the drug distribution value chain within 2 years, evolving into a more disruptive offering over time,” brokerage firm Leerink analyst Ana Gupte wrote in a note to clients.

(Newsmax wire services and Reuters and Bloomberg contributed to this report).